logo
Plus   Neg
Share
Email

Stock Alert: Aethlon Medical Jumps 45%

Shares of nano-cap company Aethlon Medical, Inc. (AEMD) jumped 45% on Wednesday morning after the company announced that first patient was treated in first-in-human clinical trial of Hemopurifier in head and neck cancer.

AEMD is currently trading at $2.33, up $0.725 or 45.1713%, on the Nasdaq.

Aethlon Medical, a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, said that the first patient has been treated in the company's first-in-human early feasibility study evaluating the Hemopurifier in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

The study is enrolling patients at UPMC Hillman Cancer Center in Pittsburgh, Pennsylvania .

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Intel Corp's Mobileye and self-driving delivery startup Udelv have signed a deal to launch a fully driverless delivery service in the United States by 2023. The companies plan to produce more than 35,000 Mobileye-driven Transporters by 2028. Domino's Pizza and autonomous vehicle startup Nuro are launching autonomous pizza delivery in Houston, this week. Some Domino's customers in Houston can have a pizza delivered by Nuro's R2 robot. CVS Health is now offering cost COVID-19 vaccines at select CVS Pharmacy locations in four more U.S. states as part of its ongoing effort to expand access to COVID-19 vaccines. It has now expanded the program to 51 more select locations in Arkansas, Nebraska, Iowa and Maine. It began in Washington, West Virginia, Delaware and New Mexico at 15 select locations from March 31.
Follow RTT